pentetic acid has been researched along with Central Nervous System Disease in 31 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Excerpt | Relevance | Reference |
---|---|---|
"Gd-DTPA is a well-characterized, safe contrast agent frequently used in magnetic resonance imaging (MRI) of the central nervous system." | 2.68 | Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. ( Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ, 1995) |
" Safety analysis was performed on 2102 patients, in whom adverse events during and up to 24 h after injection were recorded." | 2.68 | Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective. ( Aslanian, V; Borseth, A; Bunouf, P; Lemaignen, H; Lundby, B; Svaland, MG, 1996) |
" Adverse events were reported in 13 (4%) patients given gadodiamide injection and 8 (6%) given gadopentetate dimeglumine; few patients reported injection-associated discomfort." | 2.68 | MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications. ( Gordon, P; Hugo, F; Lundby, B, 1996) |
" Adverse events and serum bilirubin were the main safety parameters." | 2.67 | Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study. ( Christensen, T; Lundorf, E; Svaland, MG, 1994) |
" Adverse events were found with a similar frequency in the two groups (17." | 2.67 | Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA). ( Berry, I; Brugières, P; de Schepper, AM; Degryse, HR; Gaston, A; Le Bras, F; Manelfe, C; Marsault, C; Parizel, PM; Wichmann, W, 1994) |
" All patients received gadodiamide injection in a dosage of 0." | 2.67 | Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. ( Aisen, AM; Bradley, WG; Brant-Zawadzki, M; Dreisbach, JN; Haughton, VM; Kumar, AJ; Maravilla, KR; McNamara, MT; Sze, G; Weinreb, JC, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (25.81) | 18.7374 |
1990's | 23 (74.19) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chanalet, S | 1 |
Masson, B | 1 |
Boyer, L | 1 |
Laffont, J | 1 |
Bruneton, JN | 1 |
Aslanian, V | 2 |
Lemaignen, H | 2 |
Bunouf, P | 2 |
Schiratti, M | 1 |
Lambrechts, M | 1 |
Lundby, B | 4 |
Borseth, A | 2 |
Svaland, M | 2 |
Akeson, P | 1 |
Jonsson, E | 2 |
Haugen, I | 1 |
Holtås, S | 2 |
Nelson, KL | 2 |
Runge, VM | 3 |
Oudkerk, M | 1 |
Sijens, PE | 1 |
Van Beek, EJ | 1 |
Kuijpers, TJ | 1 |
Mehta, RC | 1 |
Pike, GB | 1 |
Haros, SP | 1 |
Enzmann, DR | 1 |
Andrew, E | 1 |
Hugo, F | 2 |
LaFrance, N | 1 |
Demaerel, P | 1 |
Marchal, G | 1 |
Wilms, G | 1 |
Van Calenbergh, F | 1 |
De Greef, D | 1 |
Børseth, A | 1 |
Baert, AL | 1 |
Svaland, MG | 2 |
Christensen, T | 1 |
Lundorf, E | 1 |
Brugières, P | 1 |
Gaston, A | 1 |
Degryse, HR | 1 |
Parizel, PM | 1 |
de Schepper, AM | 1 |
Berry, I | 1 |
Manelfe, C | 1 |
Le Bras, F | 1 |
Marsault, C | 1 |
Wichmann, W | 1 |
Haustein, J | 2 |
Laniado, M | 1 |
Niendorf, HP | 2 |
Louton, T | 1 |
Beck, W | 1 |
Planitzer, J | 1 |
Schöffel, M | 1 |
Reiser, M | 1 |
Kaiser, W | 1 |
Schörner, W | 1 |
Sze, G | 2 |
Brant-Zawadzki, M | 3 |
McNamara, MT | 3 |
Haughton, VM | 2 |
Kumar, AJ | 2 |
Maravilla, KR | 2 |
Aisen, AM | 2 |
Dreisbach, JN | 2 |
Bradley, WG | 2 |
Weinreb, JC | 2 |
Ekholm, S | 1 |
Sandvik, L | 1 |
Fagerlund, M | 1 |
Isberg, B | 1 |
Lindell, D | 1 |
Lindén, B | 1 |
Sjöberg, S | 1 |
Thuomas , KA | 1 |
Tollesson, PO | 1 |
Gordon, P | 1 |
Stevens, JM | 1 |
Sty, JR | 1 |
Babbitt, DP | 1 |
D'Souza, B | 1 |
Bolles, TF | 1 |
Bydder, GM | 1 |
Greco, A | 1 |
Lanthiez, P | 1 |
Quay, SC | 1 |
Michelozzi, G | 1 |
Gelblum, DY | 2 |
Baierl, P | 1 |
Mühlsteffen, A | 1 |
Bauer, WM | 1 |
Förster, C | 1 |
Fendel, H | 1 |
Grégoire, N | 1 |
Momose, T | 1 |
Rumeau, C | 1 |
Perot, S | 1 |
Girard, N | 1 |
Lavanga, A | 1 |
Salamon, G | 1 |
Carollo, BR | 1 |
Wolf, CR | 1 |
Castronuovo, JJ | 1 |
Chervu, LR | 1 |
Milstein, DM | 1 |
Powers, TA | 1 |
Partain, CL | 1 |
Kessler, RM | 1 |
Freeman, MW | 1 |
Robertson, RH | 1 |
Wyatt, SH | 1 |
Whelan, HT | 1 |
Mano, I | 1 |
Yoshida, H | 1 |
Kono, T | 1 |
Tsuchida, T | 1 |
Terao, H | 1 |
Iio, M | 2 |
Haley, TJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Radiation-Free Heart Catheterization Using MRI[NCT02739087] | 50 participants (Anticipated) | Interventional | 2015-03-31 | Active, not recruiting | |||
MRI Assessment of Arrythmia Ablation Lesions[NCT02761343] | 16 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Healthy Volunteers[NCT00720460] | 107 participants (Actual) | Observational | 2008-07-18 | Terminated | |||
XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization[NCT02737579] | 27 participants (Actual) | Interventional | 2013-07-23 | Active, not recruiting | |||
Technical Development for Pediatric Cardiovascular MRI[NCT02892136] | 5,000 participants (Anticipated) | Observational | 2013-05-31 | Active, not recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
7 reviews available for pentetic acid and Central Nervous System Disease
Article | Year |
---|---|
Basic principles of MR contrast.
Topics: Central Nervous System Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Gadolini | 1995 |
The spine and spinal cord.
Topics: Central Nervous System Diseases; Gadolinium; Humans; Magnetic Resonance Imaging; Myelography; Pentet | 1990 |
Technical advances in magnetic resonance imaging.
Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Gadolinium DTPA; Humans; Ma | 1992 |
Pitfalls of contrast-enhanced imaging in the nervous system.
Topics: Central Nervous System Diseases; Central Nervous System Neoplasms; Contrast Media; Costs and Cost An | 1991 |
The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolin | 1990 |
Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
Topics: Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Human | 1989 |
Saturnism, pediatric and adult lead poisoning.
Topics: Adult; Central Nervous System Diseases; Chicago; Child; Child, Preschool; Edetic Acid; Environmental | 1971 |
16 trials available for pentetic acid and Central Nervous System Disease
Article | Year |
---|---|
[Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Drug Combinations; Drug | 1995 |
[Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Female; Gadolinium | 1995 |
Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium | 1995 |
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contr | 1995 |
Clinical experience with gadodiamide injection in magnetic resonance imaging of the central nervous system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Double- | 1994 |
Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected central nervous system lesions at 1.5 T.
Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Human | 1994 |
Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Topics: Adult; Aged; Bilirubin; Blood Pressure; Central Nervous System Diseases; Contrast Media; Double-Blin | 1994 |
Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA | 1994 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadol | 1993 |
Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Inject | 1993 |
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Drug To | 1996 |
Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Central Nervous | 1996 |
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as | 1996 |
Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
Topics: Brain; Central Nervous System Diseases; Contrast Media; Drug Evaluation; Female; Gadolinium DTPA; Hu | 1991 |
Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Central Nervous System Diseases; | 1990 |
Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; | 1988 |
8 other studies available for pentetic acid and Central Nervous System Disease
Article | Year |
---|---|
Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebral Infarction; Contrast | 1995 |
Pediatric radionuclide ventriculography.
Topics: Central Nervous System Diseases; Cerebral Ventricles; Child; Child, Preschool; Humans; Indium; Infan | 1979 |
Suitability of Yb 169 DTPA for cisternography.
Topics: Animals; Central Nervous System Diseases; Dogs; Humans; Injections, Spinal; Pentetic Acid; Radioisot | 1977 |
Comparison of plain and Gd-DTPA-enhanced MR-imaging in children.
Topics: Adolescent; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Female; Gadol | 1990 |
[Gadolinium-DTPA in the study of intracranial tumors in the adult].
Topics: Adult; Aged; Brain Neoplasms; Central Nervous System Diseases; Female; Gadolinium DTPA; Glioma; Huma | 1990 |
Altered distribution of technetium-99m sodium pertechnetate associated with antimicrobial therapy.
Topics: Aged; Anti-Bacterial Agents; Brain; Central Nervous System Diseases; Drug Interactions; Erythrocytes | 1985 |
[The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnet | 1987 |
[Contrast-enhanced MRI and contrast medium development].
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Reson | 1987 |